European Pharmaceutical Manufacturer is a well-respected publication that covers the pharma/biopharma manufacturing supply chain from formulation to distribution, keeping readers informed of the latest news, opinions, developments, and advances in this cutting-edge sector. The bi-monthly publication is read by over 18,000 decision-makers and thought leaders in the European pharmaceutical manufacturing industry.
Michael Earl, director of Pharmaceutical Services at Owen Mumford, explains the progress achieved to date in terms of sustainability and the opportunities that remain.
Read the full article here